Prostasin induces protease-dependent and independent molecular changes in the human prostate carcinoma cell line PC-3

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 7, 2007, Pages 1133-1140

  Chen, Mengqian ^a   Fu, Ya Yuan ^a,c   Lin, Chen Yong ^b   Chen, Li Mei ^a   Chai, Karl X ^a  

^a UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c INSTITUTE OF ZOOLOGY   (China)

Author keywords

Epidermal Growth Factor Receptor; Matriptase; Prostate Cancer; Serine Protease

Indexed keywords

CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRIPTASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROSTASIN; PROTEINASE; TRANSCRIPTION FACTOR SLUG; UROKINASE; UROKINASE RECEPTOR; UVOMORULIN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MUTANT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; WILD TYPE;

BINDING SITES; CADHERINS; CELL LINE, TUMOR; CYCLOOXYGENASE 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; MEMBRANE PROTEINS; MUTATION; NITRIC OXIDE SYNTHASE TYPE II; PROSTATIC NEOPLASMS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 34250220661     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.04.013     Document Type: Article

References (27)

1. Chen L.M., Hodge G.B., Guarda L.A., Welch J.L., Greenberg N.M., and Chai K.X. Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer. Prostate 48 (2001) 93-103
2. Chen L.M., and Chai K.X. Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation. Int. J. Cancer 97 (2002) 323-329
3. Chen L.M., Wang C., Chen M., Marcello M.R., Chao J., Chao L., and Chai K.X. Prostasin attenuates inducible nitric oxide synthase expression in lipopolysaccharide-induced urinary bladder inflammation. Am. J. Physiol.: Renal Physiol. 291 (2006) F567-F577
4. Bruns J.B., Carattino M.D., Sheng S., Maarouf A.B., Weisz O.A., Pilewski J.M., Hughey R.P., and Kleyman T.R. Epithelial Na+ channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the gamma subunit. J. Biol. Chem. 282 (2007) 6153-6160
5. Chen L.M., Zhang X., and Chai K.X. Regulation of prostasin expression and function in the prostate. Prostate 59 (2004) 1-12
6. Chen L.M., Skinner M.L., Kauffman S.W., Chao J., Chao L., Thaler C.D., and Chai K.X. Prostasin is a glycosylphosphatidylinositol-anchored active serine protease. J. Biol. Chem. 276 (2001) 21434-21442
7. de Larco J.E., and Todaro G.J. Epithelioid and fibroblastic rat kidney cell clones: epidermal growth factor (EGF) receptors and the effect of mouse sarcoma virus transformation. J. Cell. Physiol. 94 (1978) 335-342
8. Nicholson R.I., Gee J.M., and Harper M.E. EGFR and cancer prognosis. Eur. J. Cancer 37 (2001) S9-S15
9. Oliveira S., van Bergen en Henegouwen P.M., Storm G., and Schiffelers R.M. Molecular biology of epidermal growth factor receptor inhibition for cancer therapy. Expert Opin. Biol. Ther. 6 (2006) 605-617
10. Ching K.Z., Ramsey E., Pettigrew N., D'Cunha R., Jason M., and Dodd J.G. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol. Cell. Biochem. 126 (1993) 151-158
11. Zhou W., Grandis J.R., and Wells A. STAT3 is required but not sufficient for EGF receptor-mediated migration and invasion of human prostate carcinoma cell lines. Br. J. Cancer 95 (2006) 164-171
12. Liu D.F., and Rabbani S.A. Induction of urinary plasminogen activator by retinoic acid results in increased invasiveness of human prostate cancer cells PC-3. Prostate 27 (1995) 269-276
13. Skogseth H., Larsson E., and Halgunset J. The invasive behaviour of prostatic cancer cells is suppressed by inhibitors of tyrosine kinase. APMIS 114 (2006) 61-66
14. Skogseth H., Larsson E., and Halgunset J. Inhibitors of tyrosine kinase inhibit the production of urokinase plasminogen activator in human prostatic cancer cells. APMIS 113 (2005) 332-339
15. Morton R.A., Ewing C.M., Nagafuchi A., Tsukita S., and Isaacs W.B. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells. Cancer Res. 53 (1993) 3585-3590
16. Davies G., Jiang W.G., and Mason M.D. Cell-cell adhesion molecules and signaling intermediates and their role in the invasive potential of prostate cancer cells. J. Urol. 163 (2000) 985-992
17. Savarese D.M., Valinski H., Quesenberry P., and Savarese T. Expression and function of colony-stimulating factors and their receptors in human prostate carcinoma cell lines. Prostate 34 (1998) 80-91
18. Blanchet S., Ramgolam K., Baulig A., Marano F., and Baeza-Squiban A. Fine particulate matter induces amphiregulin secretion by bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 30 (2004) 421-427
19. Netzel-Arnett S., Currie B.M., Szabo R., Lin C.Y., Chen L.M., Chai K.X., Antalis T.M., Bugge T.H., and List K. Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J. Biol. Chem. 281 (2006) 32941-32945
20. Sanders A.J., Parr C., Davies G., Martin T.A., Lane J., Mason M.D., and Jiang W.G. Genetic reduction of matriptase-1 expression is associated with a reduction in the aggressive phenotype of prostate cancer cells in vitro and in vivo. J. Exp. Ther. Oncol. 6 (2006) 39-48
21. Chen M., Chen L.M., and Chai K.X. Androgen regulation of prostasin gene expression is mediated by sterol-regulatory element-binding proteins and SLUG. Prostate 66 (2006) 911-920
22. Moreno-Bueno G., Cubillo E., Sarrio D., Peinado H., Rodriguez-Pinilla S.M., Villa S., Bolos V., Jorda M., Fabra A., Portillo F., Palacios J., and Cano A. Genetic profiling of epithelial cells expressing e-cadherin repressors reveals a distinct role for snail, slug, and e47 factors in epithelial-mesenchymal transition. Cancer Res. 66 (2006) 9543-9556
23. Oberst M.D., Chen L.Y., Kiyomiya K., Williams C.A., Lee M.S., Johnson M.D., Dickson R.B., and Lin C.Y. HAI-1 regulates activation and expression of matriptase, a membrane-bound serine protease. Am. J. Physiol.: Cell Physiol. 289 (2005) C462-C470
24. Seth D., Shaw K., Jazayeri J., and Leedman P.J. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells. Br. J. Cancer. 80 (1999) 657-669
25. El Sheikh S.S., Domin J., Abel P., Stamp G., and Lalani e.-N. Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF. Neoplasia 6 (2004) 846-853
26. Leyvraz C., Charles R.P., Rubera I., Guitard M., Rotman S., Breiden B., Sandhoff K., and Hummler E. The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J. Cell Biol. 170 (2005) 487-496
27. Yamasaki Y., Satomi S., Murai N., Tsuzuki S., and Fushiki T. Inhibition of membrane-type serine protease 1/matriptase by natural and synthetic protease inhibitors. J. Nutr. Sci. Vitaminol. (Tokyo) 49 (2003) 27-32